We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.32B
AUM Growth
-$11.8M
Cap. Flow
-$170M
Cap. Flow %
-5.1%
Top 10 Hldgs %
11.89%
Holding
1,567
New
166
Increased
531
Reduced
576
Closed
161

Sector Composition

Rank Sector Weight
1 Energy 12.89%
2 Healthcare 10.81%
3 Industrials 9.51%
4 Technology 9.45%
5 Financials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAMT icon
1376
Camtek
CAMT
$6.9B
$53K ﹤0.01%
+16,677
New +$54.6K
CERS icon
1377
Cerus
CERS
$587M
$53K ﹤0.01%
+12,800
New +$54.8K
NSPR icon
1378
InspireMD
NSPR
$32M
0
SVRA icon
1379
Savara
SVRA
$1.13B
$53K ﹤0.01%
+1,214
New +$52.9K
NG icon
1380
NovaGold Resources
NG
$2.6B
$51K ﹤0.01%
12,000
NTZ
1381
Natuzzi
NTZ
$15.6M
$51K ﹤0.01%
+4,000
New +$55.3K
ALSK
1382
DELISTED
Alaska Communications Systems
ALSK
$51K ﹤0.01%
28,500
+10,000
+54% +$18.3K
PRZM
1383
DELISTED
Prism Technologies Group, Inc
PRZM
$50K ﹤0.01%
16,000
QCLS
1384
Q/C Technologies Inc
QCLS
$25.4M
0
BSDM
1385
DELISTED
BSD MEDICAL CORP (DEL)
BSDM
$46K ﹤0.01%
46,443
+6,459
+16% +$7.2K
ARO
1386
DELISTED
Aeropostale Inc
ARO
$42K ﹤0.01%
11,900
-3,800
-24% -$16.2K
GERN icon
1387
Geron
GERN
$911M
$31K ﹤0.01%
10,580
RCPI
1388
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$24K ﹤0.01%
+1,640
New +$28.5K
IRD
1389
Opus Genetics
IRD
$254M
$23K ﹤0.01%
56
-111
-66% -$50.5K
CGRN
1390
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$23K ﹤0.01%
74
-119
-62% -$40.8K
ERN
1391
DELISTED
Erin Energy Corp
ERN
$23K ﹤0.01%
5,594
-1,029
-16% -$4.35K
BODY
1392
DELISTED
BODY CENTRAL CORP COM STK
BODY
$21K ﹤0.01%
23,791
VGZ icon
1393
Vista Gold
VGZ
$253M
$17K ﹤0.01%
34,000
ACUR
1394
DELISTED
Acura Pharmaceuticals
ACUR
$16K ﹤0.01%
3,000
-8,000
-73% -$48.5K
ONCT
1395
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$15K ﹤0.01%
8
PAL
1396
DELISTED
NORTH AMERICAN PALLADIUM LTD
PAL
$14K ﹤0.01%
50,000
GCVRZ
1397
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$14K ﹤0.01%
29,369
-200
-0.7% -$97
GGT.RT
1398
DELISTED
GABELLI MULTIMEDIA TR INC SUBSCRIPTION RT EXP 07/18/14
GGT.RT
$14K ﹤0.01%
+86,475
New +$16.5K
GMO
1399
DELISTED
General Moly, Inc.
GMO
$12K ﹤0.01%
10,000
IMUC
1400
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$11K ﹤0.01%
250

Similar funds

Oppenheimer & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Oppenheimer & Co held 1,567 positions worth $3.32B, down 0.35% from $3.34B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co withdrew a net $170M in Q2 2014, closing 161 positions and reducing 576 holdings. Its most notable exit was O'Reilly Automotive, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Energy at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oppenheimer & Co opened a new position in FOREST LABORATORIES INC worth $5.98M.

  • Oppenheimer & Co's largest Q2 2014 buy was FOREST LABORATORIES INC: 60,413 shares worth $5.98M.
  • Oppenheimer & Co added most to Kinder Morgan in Q2 2014, an estimated $5.36M increase.
  • Oppenheimer & Co's biggest Q2 2014 reduction was Monsanto Co, cutting an estimated $31.6M.
  • Oppenheimer & Co fully exited O'Reilly Automotive in Q2 2014, selling an estimated $9.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.32B portfolio in Q2 2014.
  • Oppenheimer & Co opened 166 new positions and closed 161 in Q2 2014.
  • Oppenheimer & Co's portfolio value fell 0.35% quarter-over-quarter to $3.32B.

Based on Oppenheimer & Co's 13F filing for Q2 2014, filed 14 Aug 2014.